News
Scope 41 - Independent Review praises Malaghan Research
In February of this year, a panel of independent scientists conducted a review of our...
Scope 41 - Acknowledging the efforts of three inspiring indi...
Since the Malaghan Institute first opened its doors back in 1979, it has enjoyed imme...
Scope 41 - Green Drugs
Drug discovery, such as that described above, can often require the use of large am...
Scope 41 - Immunoglycomics - the new era of drug discovery
Immunoglycomics is an emerging field of research that focuses specifically on underst...
Scope 41 - A spoonful of sugar helps the medicine go down
The Malaghan Institute of Medical Research is New Zealands premier vaccine and immun...
Scope 40 - Malaghan Institute Open Day
To celebrate its 30 year history of pioneering research into the immune system and ho...
Scope 40 - Why are some people more prone to gout?
The goal of our cancer immune therapy and infectious diseases research is to turn on ...
Scope 40 - Protecting our children from Rotavirus
Complementing the Institute's cancer vaccine programme is the research of the Infecti...
Scope 40 - Breaking news - Malaghan Institute joins effort t...
In the first of its kind for the Malaghan Institute, our considerable knowledge and c...
Scope 40 - Cancer treatment options: surgery, drugs, radiati...
An area of rapid growth at the Malaghan Institute is our cancer immunotherapy program...